Catheter-directed thrombolysis and/or thrombectomy with selective endovascular stenting as alternatives to systemic anticoagulation for treatment of acute deep vein thrombosis
“…A similar favorable outlook has been presented in a report by Sillesen et al, (19) who noted that, after an average follow-up of 24 months, iliofemoral DVT patients treated by CDT had no recurrent thromboses. Catheterdirected endovascular treatment is more effective at improving patient symptoms and removing thrombi than anticoagulant therapy alone (3,20,21). Other endovascular methods include MAT, during which the thrombus is aspirated through large-bore (7 F to 9 F) guiding catheters, and percutaneous mechanical thrombectomy, during which a mechanical device causes microfragmentation of the thrombus followed by aspiration or lysis of the clot in the vessel.…”
“…A similar favorable outlook has been presented in a report by Sillesen et al, (19) who noted that, after an average follow-up of 24 months, iliofemoral DVT patients treated by CDT had no recurrent thromboses. Catheterdirected endovascular treatment is more effective at improving patient symptoms and removing thrombi than anticoagulant therapy alone (3,20,21). Other endovascular methods include MAT, during which the thrombus is aspirated through large-bore (7 F to 9 F) guiding catheters, and percutaneous mechanical thrombectomy, during which a mechanical device causes microfragmentation of the thrombus followed by aspiration or lysis of the clot in the vessel.…”
“…Demirturk et al (30) reported that endovascular treatment of postpartum iliofemoral DVT (within 42 days of childbirth) with PAT alone or combined with CDT was rapid, very safe and resulted in a very high rate of thrombus removal in 18 patients. In a previous study (14), a pregnant woman with DVT underwent percutaneous mechanical thrombectomy with the use of venograms because pregnancy was considered a contraindication to thrombolysis. Thrombus removal using PAT with or without fluoroscopy guidance has not been used to date in pregnant women with iliofemoral DVT.…”
Section: Discussionmentioning
confidence: 99%
“…Nonetheless, there are a few publications describing thrombolytic therapy of DVT with good success during pregnancy and peri-or postpartum period (10)(11)(12)(13). In a previous study (14), a pregnant woman with DVT was treated using percutaneous mechanical thrombectomy under venographic guidance with contrast agent. Percutaneous aspiration thrombectomy (PAT) with or without fluoroscopy guidance in preg- nant women with iliofemoral DVT has not been reported to date.…”
P regnancy is a risk factor for venous thromboembolism (VTE) and the risk is highest in the postpartum period (1, 2). Anticoagulants are very effective in the prevention of pulmonary embolism (PE) and recurrent thrombosis, but the treatment of deep vein thrombosis (DVT) remains a challenge, because lysis of the thrombus formed in the deep veins is slow and frequently inadequate as a therapy (3, 4). Complete or significant lysis occurs only in 4% of patients treated with heparin alone (3). Persistence of thrombus within deep veins leads to venous hypertension, which is ultimately the cause of post-thrombotic syndrome (PTS) and late disability in 20% to 50% of patients. PTS is a conglomerate of lifestyle-limiting symptoms that commonly includes chronic leg pain and swelling, heaviness, and/or fatigue, venous claudication, stasis dermatitis, and in advanced cases skin ulcerations due to valvular incompetence accompanied by persistent venous outflow obstruction (4-8). Pregnant women are generally younger than other women in the general population, and they likely suffer a more severe form of PTS for a much longer time.Anticoagulants have been the standard therapy of DVT in pregnant women because of concerns related to administering contrast agent, exposing the fetus to radiation during interventional radiologic procedures, and bleeding complication associated with thrombolysis (9). Nonetheless, there are a few publications describing thrombolytic therapy of DVT with good success during pregnancy and peri-or postpartum period (10-13). In a previous study (14), a pregnant woman with DVT was treated using percutaneous mechanical thrombectomy under venographic guidance with contrast agent. Percutaneous aspiration thrombectomy (PAT) with or without fluoroscopy guidance in preg-
71From the Department of Radiology (M.G.
“…High success rates of clot lysis have been reported in studies assessing the effect of combining CDT with PMT, balloon maceration, or aspiration thrombectomy [161][162][163][164][165][166][167]. Although these methods are generally considered as safe treatments with lower dose and shorter treatment time, they have not been documented by large randomized controlled trials.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.